Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Heart Failure Reports
|
February 19, 2025
Prevention of cancer-therapy related cardiac dysfunction
Elias Haj-Yehia, Lars Michel, Raluca I Mincu, et al.
British Journal of Pharmacology
|
March 11, 2026
Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio-oncology Registry
Elias Haj-Yehia, Lisa Zimmer, Lena Lampe, et al.
International Journal of Cardiology. Heart & Vasculature
|
August 25, 2025
Hemoglobin is associated with cardiotoxicity in melanoma patients without anemia receiving immune checkpoint inhibitor therapy
Elias Haj-Yehia, Raluca I Mincu, Phillip Schulte, et al.
Journal of Visualized Experiments : Jove
|
October 13, 2025
Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy
Sebastian Korste, Elias Haj-Yehia, Simon F Merz, et al.
Diabetes, Obesity & Metabolism
|
July 24, 2018
Myocardial infarction is sufficient to increase GLP-1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacity
Sebastian Diebold, Julia Moellmann, Florian Kahles, et al.
British Journal of Pharmacology
|
June 16, 2026
Refining the treatment of immune checkpoint inhibitor-associated myocarditis: Challenges, innovations and rechallenge considerations
Raluca I Mincu, Lisa Zimmer, Dimitra Vlachopoulou, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
November 13, 2023
High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapy
Elias Haj-Yehia, Raluca I Mincu, Sebastian Korste, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 29, 2026
Evaluation of neutrophil oxidative burst capacity in relation to major adverse cardiac events and infection in patients with cardiovascular disease
Elias Haj-Yehia, Phillip Schulte, Christian Fehring, et al.
International Journal of Molecular Sciences
|
April 13, 2023
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart
Sebastian Korste, Stephan Settelmeier, Lars Michel, et al.
Journal of Clinical Medicine
|
December 9, 2020
Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction
Elias Haj-Yehia, Robert Werner Mertens, Florian Kahles, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Heart Failure Reports
|
February 19, 2025
Prevention of cancer-therapy related cardiac dysfunction
Elias Haj-Yehia, Lars Michel, Raluca I Mincu, et al.
British Journal of Pharmacology
|
March 11, 2026
Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio-oncology Registry
Elias Haj-Yehia, Lisa Zimmer, Lena Lampe, et al.
International Journal of Cardiology. Heart & Vasculature
|
August 25, 2025
Hemoglobin is associated with cardiotoxicity in melanoma patients without anemia receiving immune checkpoint inhibitor therapy
Elias Haj-Yehia, Raluca I Mincu, Phillip Schulte, et al.
Journal of Visualized Experiments : Jove
|
October 13, 2025
Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy
Sebastian Korste, Elias Haj-Yehia, Simon F Merz, et al.
Diabetes, Obesity & Metabolism
|
July 24, 2018
Myocardial infarction is sufficient to increase GLP-1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacity
Sebastian Diebold, Julia Moellmann, Florian Kahles, et al.
British Journal of Pharmacology
|
June 16, 2026
Refining the treatment of immune checkpoint inhibitor-associated myocarditis: Challenges, innovations and rechallenge considerations
Raluca I Mincu, Lisa Zimmer, Dimitra Vlachopoulou, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
November 13, 2023
High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapy
Elias Haj-Yehia, Raluca I Mincu, Sebastian Korste, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 29, 2026
Evaluation of neutrophil oxidative burst capacity in relation to major adverse cardiac events and infection in patients with cardiovascular disease
Elias Haj-Yehia, Phillip Schulte, Christian Fehring, et al.
International Journal of Molecular Sciences
|
April 13, 2023
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart
Sebastian Korste, Stephan Settelmeier, Lars Michel, et al.
Journal of Clinical Medicine
|
December 9, 2020
Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction
Elias Haj-Yehia, Robert Werner Mertens, Florian Kahles, et al.
Page
of 2